# UnitedHealth Group account plan

> UnitedHealth Group runs UnitedHealthcare health benefits and Optum health services, with $447,567 million of 2025 revenues and 390,000+ employees.

## At a glance

UnitedHealth Group, headquartered in Eden Prairie, Minnesota, runs two businesses: UnitedHealthcare, which offers health benefits to employers, individuals, seniors and state programs, and Optum, which provides care delivery, pharmacy services, data and technology to patients, providers, payers and life sciences companies. In 2025 revenues were $447,567 million (+12%), earnings from operations $18,964 million (-41%) and net earnings to shareholders $12,056 million. Premium revenues from CMS represented 44% of consolidated revenues. At December 31, 2025 it had more than 390,000 employees, nearly 165,000 of them clinical professionals.

## Business units

- **UnitedHealthcare Employer & Individual** ($79,228 million of 2025 revenues): Health benefits for large national, public-sector, mid-sized and small employers and individuals, giving 29.7 million people access to medical services. Commercial risk-based members fell 8% in 2025 while fee-based members rose 3%.
- **UnitedHealthcare Medicare & Retirement** ($171,285 million of 2025 revenues): The largest business: Medicare Advantage (8.4 million people), Medicare Part D and Medicare Supplement. Revenues rose 23% in 2025, but Medicare Advantage funding reductions and higher medical costs cut margins, and MA enrollment is expected to decline by about 1.1 million in 2026.
- **UnitedHealthcare Community & State** ($94,390 million of 2025 revenues): Medicaid, CHIP, Dual SNPs and long-term services and supports in 32 states and the District of Columbia, for nearly 7.4 million people. Margins are pressured for 2026 and membership is falling with reduced eligibility and the Louisiana exit.
- **Optum Health** ($101,957 million of 2025 revenues (about 23% of consolidated revenue, computed)): Primary, specialty, in-home, virtual and behavioral care, largely under value-based arrangements, caring for over 20 million patients. It swung to a 2025 operating loss of $278 million and is re-centering on its integrated value-based model, targeting long-term margins of 6% to 8%.
- **Optum Insight** ($19,417 million of 2025 revenues (about 4% of consolidated revenue, computed)): Data, analytics, technology and managed services for health systems, health plans, state governments and life sciences, with a backlog of about $31.1 billion at end-2025. It took over Optum Financial in 2026 and completed the acquisition of Alegeus on July 2, 2026.
- **Optum Rx** ($154,726 million of 2025 revenues (about 35% of consolidated revenue, computed)): Pharmacy care services through about 64,000 retail pharmacies, home delivery, specialty and infusion pharmacies, managing $188 billion of pharmaceutical spending in 2025. It is moving to a fee-based, transparent pharmacy model with full rebate pass-through.

## Strategic priorities

- **Value-based care**: The company aims to "accelerate the transition from fee-for-service care delivery and payment models to fully accountable value-based care", integrating in-clinic, in-home, behavioral and virtual care.
- **Margin recovery over membership**: UnitedHealthcare's 2026 approach prioritized margin recovery and product stability, accepting fewer members; MA membership is expected to contract and Medicare margins to stay above 3%.
- **AI-led modernisation**: UnitedHealth is investing nearly $1.5 billion in AI-related initiatives in 2026, from ambient listening for providers to AI-enabled coding and digital prior authorization.
- **Prior authorization reform**: UnitedHealthcare commits to eliminate 30% of prior authorization volume and nearly two-thirds of pediatric requirements by end-2026, with more than 70% of prior approvals in a standardized electronic process.
- **Transparent pharmacy model**: Optum Rx is rolling out a fee-based model with 100% pass-through of manufacturer rebates by January 1, 2028, and expects more than 95% of clients on full pass-through by end-2026.
- **Focus on US health care**: The group has exited non-US businesses, refreshed nearly half of its top 100 leadership roles and targets debt-to-capital of about 40% by end-2026.

## Latest results

In Q2 2026 revenues were $112,032 million against $111,616 million a year earlier, earnings from operations rose 55% to $7,991 million and net earnings attributable to shareholders rose 61% to $5,484 million. The medical care ratio fell to 86.7% from 89.4%, including $860 million of net favorable reserve development. UnitedHealthcare served 48.5 million people, down 525,000 sequentially, while Optum Health revenues fell 5% on fewer value-based-care patients. On July 16, 2026 the company raised its 2026 adjusted EPS outlook to $19.50 to $20.00 and its operating cash flow outlook to about $24,000 million.

## Investments and deals

- **AI programme**: Nearly $1.5 billion in AI-related initiatives in 2026; AI ambient listening is available to 70% of employed Optum Health providers, on track to exceed 90% by year-end.
- **Alegeus acquisition**: Optum Financial Services agreed to acquire Alegeus Technologies (consumer-directed health accounts); the deal completed on July 2, 2026.
- **Portfolio divestitures**: A Q4 2025 strategic review produced a net portfolio divestitures gain of $568 million; South American businesses were held for sale and the UK business was sold for a $525 million gain.
- **Restructuring**: Restructuring and other actions of $2.5 billion in 2025, including $746 million of real estate rationalization and workforce reductions and a $623 million loss contract reserve for 2026 value-based care losses.
- **Capital returns**: At least $5 billion of share repurchases planned for 2026, and the dividend raised in June 2026 to an annual $9.28 per share.

## Challenges and risks

- **Medicare Advantage funding**: MA rate notices remain below forward medical cost trend and risk adjustment revisions keep reducing funding; MA seniors fell 965,000 since year-end 2025.
- **Elevated medical costs**: The 2025 medical care ratio rose to 89.1% from 85.5%; commercial trend is modestly above the 11% level, driven by the No Surprises Act dispute process and provider coding intensity.
- **Medicaid rates**: Medicaid funding "remains insufficient", with negative margins expected in 2026 and modest margin improvements beginning in 2027.
- **Regulatory and legal scrutiny**: A DOJ False Claims Act case on Medicare risk adjustment submissions remains pending, CMS and OIG RADV audits may lead to payment adjustments, and PBM practices face investigation.
- **Cyber risk**: Optum Insight still carries the legacy of the February 21, 2024 Change Healthcare cyberattack, with $799 million of additional reserves in Q4 2025.

## What leadership says

> "We have refocused the organization squarely on U.S. health care, exiting non-U.S. businesses. We have refreshed nearly half of our top 100 leadership roles." — Stephen Hemsley, Chair and CEO, Q1 2026 results prepared remarks, April 21, 2026

> "This is not just a matter of being more productive at what we already do, but a reimagining of how we organize, operate and work going forward." — Stephen Hemsley, Chair and CEO, Q1 2026 results prepared remarks, April 21, 2026

> "Commercial costs are stubbornly high" — Tim Noel, CEO of UnitedHealthcare, Q2 2026 results prepared remarks, July 16, 2026

> "AI is both an enabler and an accelerant." — Tim Noel, CEO of UnitedHealthcare, Q2 2026 results prepared remarks, July 16, 2026


## Where a supplier can help

- **AI for clinical and administrative workflows**: Tied to the nearly $1.5 billion AI programme: vendors of ambient documentation, coding automation or contact-centre AI can align with the stated goal of reimagining how the enterprise operates.
- **Prior authorization and interoperability**: Tied to the prior authorization reform commitments: electronic prior authorization, payer-provider data exchange and gold-carding tools support the end-2026 targets.
- **Medical cost management**: Tied to the elevated-medical-cost challenge: payment integrity, care management and billing-review solutions address commercial trend above the 11% level.
- **Value-based care enablement**: Tied to the value-based care priority and Optum Health's 6% to 8% margin target: analytics, home health and transition-of-care tools that reduce hospitalizations.
- **Security and compliance**: Tied to the cyber risk and regulatory scrutiny challenges: cybersecurity, audit readiness and risk adjustment documentation tools.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Annual Report on Form 10-K for fiscal year 2025 (year ended December 31, 2025)](https://www.sec.gov/Archives/edgar/data/731766/000073176626000062/unh-20251231.htm)

Annual report · 2026-03-02

- UnitedHealth Group is a US health care and well-being company built on two businesses, Optum (care delivery, health tech and services, pharmacy care) and UnitedHealthcare (health benefits), reported as four segments: Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. More than 390,000 employees, of whom nearly 165,000 are clinical professionals.
- 2025 revenues of $447,567 million (+12%), but earnings from operations fell to $18,964 million from $32,287 million (-41%); operating margin 4.2% vs 8.1%; diluted EPS $13.23 vs $15.51. Medical care ratio rose to 89.1% from 85.5%: pricing "well-short of the medical cost trends incurred".
- UnitedHealthcare revenues $344,903 million (+16%), operating margin 2.7%; it served 49,760 thousand people (29,650 thousand commercial, 8,445 thousand Medicare Advantage, 7,380 thousand Medicaid). Premium revenues from CMS were 44% of consolidated revenues.
- Optum revenues $270,620 million (+7%), operating margin 3.5%: Optum Rx $154,726 million (managed $188 billion of drug spend, 1,659 million adjusted scripts), Optum Health $101,957 million with a $278 million operating loss, Optum Insight $19,417 million with a $31.1 billion backlog.
- Q4 2025 strategic review: net portfolio divestitures gain of $568 million and $2.5 billion of restructuring and other actions (real estate and workforce reductions, a $623 million loss-contract reserve for 2026 value-based care losses), plus $799 million of extra reserves on Change Healthcare cyberattack provider loans.
- Outlook in the filing: Medicare Advantage membership and value-based care patients expected to contract in 2026; the Advance Notice for 2027 MA rates is "far below" forward cost trend; Medicaid funding "remains insufficient".
- On January 1, 2026 Optum Financial (incl. Optum Bank: nearly 26 million accounts, more than $27 billion in assets) moved from Optum Health to Optum Insight.
- New leadership: Stephen Hemsley Chair and CEO since May 2025, CFO Wayne DeVeydt since September 2025, Patrick Conway CEO of Optum since May 2025, Tim Noel CEO of UnitedHealthcare since January 2025.
- Main risks: medical cost estimation and pricing, government program funding and RADV/risk-adjustment audits, cyberattacks, AI use, PBM regulation, and the 2017 DOJ False Claims Act case on risk adjustment submissions.

### [Quarterly Report on Form 10-Q for Q2 2026 (quarter ended June 30, 2026)](https://www.sec.gov/Archives/edgar/data/731766/000073176626000197/unh-20260630.htm)

Interim report · 2026-08-10

- Q2 2026 revenues $112,032 million, flat year on year; earnings from operations $7,991 million (+55%); diluted EPS $6.04 vs $3.74; medical care ratio 86.7% vs 89.4%.
- UnitedHealthcare earnings from operations $3,942 million (+90%), margin 4.6%; it served 48,525 thousand people, 1,590 thousand fewer than a year earlier, after benefit design and pricing actions, reduced Medicaid eligibility and a state exit.
- Medicare Advantage members 7,565 thousand (-9%), Medicaid 6,780 thousand (-9%), risk-based commercial 7,655 thousand (-9%), fee-based commercial 22,265 thousand (+3%).
- Optum Health earnings $1,190 million (+177%), margin 5.1%, on revenues down 5%; Optum Insight margin 25.3%; Optum Rx scripts 387 million vs 414 million.
- Commercial cost trend is elevated by the No Surprises Act independent resolution process and "more aggressive billing practice among providers".
- The company pledged to rebate 2026 profits on individual exchange products; the 2027 Medicare Advantage Final Notice "moved towards" forward cost trend but "remains below".
- H1 operating cash flow $19,964 million; $3.0 billion health care acquisition closed July 2, 2026; dividend raised to $9.28 annualised.

### [UnitedHealth Group Reports Second Quarter 2026 Results (earnings release, Exhibit 99.1)](https://www.sec.gov/Archives/edgar/data/731766/000073176626000191/earningsrelease2q26_7152.htm)

Interim report · 2026-07-16

- Q2 2026 revenues $112.0 billion; earnings from operations $8.0 billion (Q2 2025: $5.2 billion); EPS $6.04, adjusted EPS $6.38.
- 2026 outlook raised: adjusted EPS $19.50 to $20.00 (from > $17.75 in January), diluted EPS $18.45 to $18.95, operating earnings > $25,450 million, MCR 88.1% ± 25 bps, operating cash flow ~$24,000 million, buybacks at least $5,000 million.
- Segment guidance: UnitedHealthcare > $12,000 million, Optum Health > $2,275 million, Optum Insight > $4,925 million, Optum Rx > $6,250 million of operating earnings.
- UnitedHealthcare served 48.5 million people; MA seniors down 965,000 since year-end 2025; Community & State down 380,000 in the quarter, mainly from the planned exit from the Louisiana health plan.
- Optum supported more than 120 million consumers; revenues $65.7 billion, earnings $4.0 billion, +160 bps margin.
- Reform agenda: eliminate 30% of prior approval volume by end-2026, rebate 2026 ACA profits to about 1 million members, support 1,500 rural hospitals, a fully transparent fee-based pharmacy model, $1 billion committed to the United Health Foundation.
- Optum Insight completed the Alegeus acquisition on July 2, 2026; debt-to-capital 41.2%, target about 40.0% by year-end.

### [Second Quarter 2026 Results: teleconference prepared remarks (Hemsley, Noel, Conway, DeVeydt)](https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2026/unh-q2-2026-remarks.pdf)

Executive talk · Stephen Hemsley, Chair and Chief Executive Officer · 2026-07-16

- Hemsley: results show "continuing progress toward delivering more consistent and dependable performance"; Optum Health is re-centering on its integrated value-based care model; Optum Insight is on "a multi-year path of reinvestment and innovation".
- Medicare cost trend still "well above historical levels" but below plan; 2026 Medicare trend expected below the initial ~10% estimate; MA enrollment to fall by about 1.1 million in 2026, Medicare margins above 3%.
- Commercial costs "stubbornly high": trend modestly above 11%, driven by the No Surprises Act dispute process and provider billing intensity; commercial margin recovery will take longer than planned.
- Commitments: eliminate 30% of prior authorization volume and nearly two-thirds of pediatric prior authorization requirements by end-2026.
- Optum Health: about 10% fewer hospitalizations from transition-of-care support in the West and South; ambient AI listening available to 70% of employed providers, over 90% by year-end; 20 million patients.
- Optum Rx: monthly per-member fee pharmacy model launched in May; more than 95% of clients on 100% rebate pass-through by end-2026; retention "in the high 90s".
- CFO DeVeydt: adjusted EPS guidance $19.50 to $20; buybacks at least $5 billion; debt-to-capital to about 40% by end-2026.

### [First Quarter 2026 Results: teleconference prepared remarks (Hemsley, Noel, Conway, DeVeydt)](https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2026/unh-q1-2026-remarks.pdf)

Executive talk · Stephen Hemsley, Chair and Chief Executive Officer · 2026-04-21

- Hemsley: all major segments exceeded plan in Q1 2026; the group has "refocused the organization squarely on U.S. health care, exiting non-U.S. businesses" and refreshed "nearly half of our top 100 leadership roles".
- Nearly $1.5 billion to be invested in AI-related initiatives in 2026; the AI agenda is "a reimagining of how we organize, operate and work going forward".
- Governance: new Public Responsibility Committee of the Board, a new Lead Independent Director and a new independent director.
- UnitedHealthcare chose "margin recovery and product stability" over growth; MA membership expected to contract by about 1.3 million; individual ACA membership to fall about one-third; 2026 ACA profits refunded.
- Prior authorization: nearly 95% submitted electronically, medical prior authorizations to be cut by 30% or more by year-end; rural hospitals get 50% faster payments.
- Optum Health: over 20 million patients, over 4 million in fully value-based arrangements; long-term margin target 6% to 8%; Optum Rx onboarded more than 800 new clients; Optum Financial agreed to acquire Alegeus.
- CFO: adjusted EPS $7.23, revenues $111.7 billion; full-year outlook raised to greater than $18.25; $525 million gain on the sale of the UK business.

## Questions about UnitedHealth Group

### What does UnitedHealth Group do?

UnitedHealth Group runs UnitedHealthcare, which offers health benefits to employers, individuals, seniors and state programs, and Optum, which provides care delivery, pharmacy services, data and technology. Its headquarters are in Eden Prairie, Minnesota.

### What was UnitedHealth Group's revenue in 2025?

Revenues were $447,567 million in 2025 (+12%), with net earnings to shareholders of $12,056 million.

### How many employees does UnitedHealth Group have?

More than 390,000 employees as of December 31, 2025, nearly 165,000 of them clinical professionals.

### Who leads UnitedHealth Group?

Stephen Hemsley has been Chair and CEO since May 2025; Wayne DeVeydt is CFO, Dr. Patrick Conway is CEO of Optum and Tim Noel is CEO of UnitedHealthcare.

### What is UnitedHealth Group's strategy?

It is refocusing on US health care, prioritizing margin recovery over membership growth, moving toward fully accountable value-based care, and investing in AI to modernize operations.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
